Biomedical Consulting International, Inc has extensive experience in the development of product development strategies to enable new chemical/biological entities and/or new dosage forms of existing entities and/or new/improved medical devices to move from Phase I to Phase II clinical trials as expeditiously as possible. BCI Phase II Clinical Services may take many forms:

• From strategic oversight;
  
• To partnering with the client to develop the clinical trial design and the rest of the support package; this may also include the preparation for and attendance at meetings with regulatory authorities associated with the Phase II program;
  
• To BCI performing all services required on behalf of the client to enable the entry into Phase II.